203 related articles for article (PubMed ID: 25349921)
1. Tumor necrosis factor alpha protects heart cultures against hypoxic damage via activation of PKA and phospholamban to prevent calcium overload.
El-Ani D; Philipchik I; Stav H; Levi M; Zerbib J; Shainberg A
Can J Physiol Pharmacol; 2014 Nov; 92(11):917-25. PubMed ID: 25349921
[TBL] [Abstract][Full Text] [Related]
2. Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes.
Zinman T; Shneyvays V; Tribulova N; Manoach M; Shainberg A
J Cell Physiol; 2006 Apr; 207(1):220-31. PubMed ID: 16331687
[TBL] [Abstract][Full Text] [Related]
3. Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis.
Wei J; Xu H; Shi L; Tong J; Zhang J
Chem Biol Interact; 2015 Jul; 236():47-56. PubMed ID: 25937560
[TBL] [Abstract][Full Text] [Related]
4. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.
Younce CW; Burmeister MA; Ayala JE
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C508-18. PubMed ID: 23302777
[TBL] [Abstract][Full Text] [Related]
5. Exogenous nitric oxide triggers classic ischemic preconditioning by preventing intracellular Ca2+ overload in cardiomyocytes.
Rickover O; Zinman T; Kaplan D; Shainberg A
Cell Calcium; 2008 Apr; 43(4):324-33. PubMed ID: 17692373
[TBL] [Abstract][Full Text] [Related]
6. [Effects of tumor necrosis factor alpha on expression of phospholamban and intracellular calcium in cardiomyocytes].
Yao YM; Hu SJ; Huang YW; Yang CH; Sun J; Zhu ZH; Wu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):767-71. PubMed ID: 16447655
[TBL] [Abstract][Full Text] [Related]
7. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
8. Phospholamban pentamers attenuate PKA-dependent phosphorylation of monomers.
Wittmann T; Lohse MJ; Schmitt JP
J Mol Cell Cardiol; 2015 Mar; 80():90-7. PubMed ID: 25562800
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV alleviates hypoxia/reoxygenation-induced neonatal rat cardiomyocyte injury via the protein kinase a pathway.
Zhang DW; Bian ZP; Xu JD; Wu HF; Gu CR; Zhou B; Chen XJ; Yang D
Pharmacology; 2012; 90(1-2):95-101. PubMed ID: 22797566
[TBL] [Abstract][Full Text] [Related]
10. Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II.
Xu J; Han Q; Shi H; Liu W; Chu T; Li H
Int J Mol Med; 2017 Aug; 40(2):499-504. PubMed ID: 28656205
[TBL] [Abstract][Full Text] [Related]
11. Activation of CaMKIIδA promotes Ca
Gui L; Guo X; Zhang Z; Xu H; Ji YW; Wang RJ; Zhu JH; Chen QH
Acta Pharmacol Sin; 2018 Oct; 39(10):1604-1612. PubMed ID: 29900930
[TBL] [Abstract][Full Text] [Related]
12. HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.
Sivakumaran V; Stanley BA; Tocchetti CG; Ballin JD; Caceres V; Zhou L; Keceli G; Rainer PP; Lee DI; Huke S; Ziolo MT; Kranias EG; Toscano JP; Wilson GM; O'Rourke B; Kass DA; Mahaney JE; Paolocci N
Antioxid Redox Signal; 2013 Oct; 19(11):1185-97. PubMed ID: 23919584
[TBL] [Abstract][Full Text] [Related]
13. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
[TBL] [Abstract][Full Text] [Related]
15. Maximal acceleration of Ca2+ release refractoriness by β-adrenergic stimulation requires dual activation of kinases PKA and CaMKII in mouse ventricular myocytes.
Poláková E; Illaste A; Niggli E; Sobie EA
J Physiol; 2015 Mar; 593(6):1495-507. PubMed ID: 25772298
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin (sirolimus) protects against hypoxic damage in primary heart cultures via Na+/Ca2+ exchanger activation.
El-Ani D; Stav H; Guetta V; Arad M; Shainberg A
Life Sci; 2011 Jul; 89(1-2):7-14. PubMed ID: 21600903
[TBL] [Abstract][Full Text] [Related]
17. Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway.
Shi H; Han Q; Xu J; Liu W; Chu T; Zhao L
Gene; 2016 May; 583(1):8-14. PubMed ID: 26930364
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol protects against lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization.
Bai T; Hu X; Zheng Y; Wang S; Kong J; Cai L
Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H1051-H1062. PubMed ID: 27591219
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12.
Chen Z; Akin BL; Jones LR
J Biol Chem; 2007 Jul; 282(29):20968-76. PubMed ID: 17548345
[TBL] [Abstract][Full Text] [Related]
20. Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection.
Inserte J; Hernando V; Ruiz-Meana M; Poncelas-Nozal M; Fernández C; Agulló L; Sartorio C; Vilardosa U; Garcia-Dorado D
Cardiovasc Res; 2014 Sep; 103(4):542-53. PubMed ID: 25020913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
